NextCure Inc Investor & Analyst Oncology Pipeline Update Event Transcript
Good day, and thanks for standing by. Welcome to the NextCure Investor and Analyst Oncology Pipeline Update.
(Operator Instructions)
As a reminder, this conference call is being recorded. I would now like to turn the call over to Mr. Tim Mayer, Chief Operating Officer at NextCure. Please go ahead.
Thank you, operator. Good afternoon. My name is Timothy Mayer, Chief Operating Officer. Welcome to NextCure's virtual R&D update conference call and webcast. You can also join this conference call on NextCure's website at nextcure.com.
We're using slides to accompany our remarks today, which also can be accessed from the Investor Relations section of our website. A replay of this conference call will also be available on our website following today's presentation.
I'd like to introduce NextCure's President and Chief Executive Officer, Michael Richman; our Chief Medical Officer, Dr. Han Myint; and Dr. Roy Herbst, a key opinion leader in lung cancer from
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
